Mark A. Guthridge

Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells

Liqing Jin, Erwin M. Lee, Hayley S. Ramshaw et al. · Cell stem cell · 2009 · 523 citations · Full text

Hematological Malignancy, Cell Therapy, Immune Cell Development +10

The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation

Guido Hansen, Timothy R. Hercus, Barbara J. McClure et al. · Cell · 2008 · 302 citations · Full text

Inflammation, Cytokine Receptor Activation, Gm-csf Receptor Complex +13

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

T.-C. Teh, N-Y Nguyen, Donia M. Moujalled et al. · Leukemia · 2017 · 149 citations

Hematological Malignancy, Tumor Biology, Mixed-phenotype Acute Leukemia +10

Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts, Amanda M. Smith, Fiona McDougall et al. · Cancer Research · 2010 · 130 citations · Full text

Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency

Pike-See Cheah, Hayley S. Ramshaw, Paul Q. Thomas et al. · Molecular Psychiatry · 2011 · 108 citations

Neurodevelopmental Disorders, Developmental Anomaly, Psychiatry +7